Description

B7-33 represents a synthetic peptide derived from the B-chain of relaxin-3, designed to investigate relaxin family peptide receptor signaling and cardiovascular regulation mechanisms. The compound demonstrates selective activity at RXFP1 (relaxin family peptide receptor 1) and has been characterized for its cardiovascular and other physiological effects in research models. B7-33 functions through specific binding to RXFP1 receptors, leading to activation of signaling pathways involved in cardiovascular regulation, tissue remodeling, and other relaxin-mediated processes. The peptide has been utilized in research investigating the cardiovascular effects of relaxin signaling, including vasodilation, cardiac protection, and vascular remodeling mechanisms. Research applications include investigation of relaxin biology, cardiovascular regulation mechanisms, reproductive physiology, and the role of relaxin family peptides in various physiological and pathological processes. For research use only.